Mangoceuticals, Inc.
MGRX· Nasdaq
MGRXMangoceuticals, Inc.
Filed Jul 28, 2023 · 10-Q · 28 days after period end · 0001493152-23-025879
| Metric | Q2 2023 | Q2 2022 |
|---|---|---|
| Revenue | $141.24K | — |
| Net Income | -$2.28M | -$310.19K |
| EPS Diluted | -$0.14 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mangoceuticals, Inc. · CIK 1938046 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Jul 28, 2023 · 28 d after period end
